Literature DB >> 19673035

Human umbilical cord blood-derived stromal cells suppress xenogeneic immune cell response in vitro.

Lei Hao1, Cheng Zhang, Xing-Hua Chen, Zhong-Min Zou, Xi Zhang, Pei-Yan Kong, Xue Liang, Lei Gao, Xian-Gui Peng, Ai-Hua Sun, Qing-Yu Wang.   

Abstract

AIM: To explore immunological properties of human umbilical cord blood-derived stromal cells (hUCBDSC) and their effect on xenogeneic immune cells in vitro.
METHODS: Immunological phenotype of freshly isolated and cryopreserved hUCBDSCs was evaluated by flow cytometry. Xenogeneic splenic T-cells were stimulated by phytohemaglutinin A (PHA) or dendritic cells in the absence or presence of hUCBDSCs. T-cell proliferation was measured by cell counting kit-8 after 7-day incubation. The proportion of apoptotic cells and CD4+CD25+Foxp3+ regulatory T-cells (Tregs) was determined in T-cells activated by PHA in the absence or presence of hUCBDSCs by flow cytometry. Phenotype of dendritic cells, cultured alone or with hUCBDSCs, was analyzed by flow cytometry.
RESULTS: Levels of immune molecule expression on freshly isolated hUCBDSCs were as follows: human leukocyte antigen-I (HLA-I) (84.1+/-2.9%), HLA-II (1.6+/-0.3%), CD80 (0.8+/-0.1%), CD86 (0.8+/-0.1%), CD40 (0.6+/-0.1%), and CD40L (0.5+/-0.1%), which was not influenced by cryopreservation. T-cell proliferation in the presence of hUCBDSCs was significantly lower than that of positive control. The coculture led to a 10-fold increase (from 1.2+/-0.3% to 12.1+/-1.4%, P<0.001) in the proportion of CD4+CD25+Foxp3+ regulatory T-cells (Tregs) and a reversion of mature dendritic cells, as indicated by the down-regulation of major histocompatibility complex (MHC)-II molecule (49.3% vs 25.9%, P=0.001), CD80 (47.2% vs 23.3%, P=0.001), and CD86 (40.6% vs 25.1%, P=0.002). When subjected to annexin V binding and propidium iodide uptake assay, the hUCBDSCs did not show the ability to induce apoptosis of xenogeneic T-cells.
CONCLUSION: These results demonstrate low immunogenicity and immunomodulation effect of the hUCBDSCs. Reversion of mature dendritic cells and increase in Treg proportion, but not cell apoptosis, can possibly contribute to the suppression of xenogeneic T-cell proliferation by the hUCBDSCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19673035      PMCID: PMC2728383          DOI: 10.3325/cmj.2009.50.351

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  68 in total

1.  Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment.

Authors:  O Annacker; O Burlen-Defranoux; R Pimenta-Araujo; A Cumano; A Bandeira
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

2.  Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

Authors:  S Webb; C Morris; J Sprent
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

Review 3.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

Review 4.  Marrow stromal stem cells.

Authors:  M Owen
Journal:  J Cell Sci Suppl       Date:  1988

5.  Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.

Authors:  R Korngold; J Sprent
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

6.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

7.  Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation.

Authors:  S Nishida; N Endo; H Yamagiwa; T Tanizawa; H E Takahashi
Journal:  J Bone Miner Metab       Date:  1999       Impact factor: 2.626

8.  Bilateral diffuse pulmonary ectopic ossification after marrow allograft in a dog. Evidence for allotransplantation of hemopoietic and mesenchymal stem cells.

Authors:  G E Sale; R Storb
Journal:  Exp Hematol       Date:  1983-11       Impact factor: 3.084

9.  Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.

Authors:  T Sasazuki; T Juji; Y Morishima; N Kinukawa; H Kashiwabara; H Inoko; T Yoshida; A Kimura; T Akaza; N Kamikawaji; Y Kodera; F Takaku
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

10.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  11 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

2.  Human umbilical cord blood-derived stromal cells, a new resource in the suppression of acute graft-versus-host disease in haploidentical stem cell transplantation in sublethally irradiated mice.

Authors:  Cheng Zhang; Xing-Hua Chen; Xi Zhang; Lei Gao; Pei-Yan Kong; Xian-gui Peng; Xue Liang; Li Gao; Yi Gong; Qing-Yu Wang
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

3.  Effect of intracameral human cord blood-derived stem cells on lasered rabbit trabecular meshwork.

Authors:  Ramanjit Sihota; Seema Sen; Sujata Mohanty; Mohammad Ahmad; Alok Ravi; Viney Gupta; Neerja Bhatla
Journal:  Int Ophthalmol       Date:  2019-05-28       Impact factor: 2.031

4.  Application of human umbilical cord blood-derived mesenchymal stem cells in disease models.

Authors:  Ju-Yeon Kim; Hong Bae Jeon; Yoon Sun Yang; Wonil Oh; Jong Wook Chang
Journal:  World J Stem Cells       Date:  2010-04-26       Impact factor: 5.326

5.  Human umbilical cord blood-derived stromal cells are superior to human umbilical cord blood-derived mesenchymal stem cells in inducing myeloid lineage differentiation in vitro.

Authors:  Hao-Ping Sun; Xi Zhang; Xing-Hua Chen; Cheng Zhang; Lei Gao; Yi-Mei Feng; Xian-Gui Peng; Li Gao
Journal:  Stem Cells Dev       Date:  2011-12-05       Impact factor: 3.272

6.  Human umbilical cord mesenchymal stem cells as treatment of adjuvant rheumatoid arthritis in a rat model.

Authors:  Sahar Greish; Noha Abogresha; Zeinab Abdel-Hady; Eman Zakaria; Mona Ghaly; Mohamed Hefny
Journal:  World J Stem Cells       Date:  2012-10-26       Impact factor: 5.326

Review 7.  Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells.

Authors:  Pei-Min Chen; Men-Luh Yen; Ko-Jiunn Liu; Huey-Kang Sytwu; B-Linju Yen
Journal:  J Biomed Sci       Date:  2011-07-18       Impact factor: 8.410

8.  Reconstruction of hematopoietic inductive microenvironment after transplantation of VCAM-1-modified human umbilical cord blood stromal cells.

Authors:  Yao Liu; Xing-hua Chen; Ying-jian Si; Zhong-jun Li; Lei Gao; Li Gao; Cheng Zhang; Xi Zhang
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

9.  Human umbilical cord blood-derived mesenchymal stem cells promote regeneration of crush-injured rat sciatic nerves.

Authors:  Mi-Ae Sung; Hun Jong Jung; Jung-Woo Lee; Jin-Yong Lee; Kang-Mi Pang; Sang Bae Yoo; Mohammad S Alrashdan; Soung-Min Kim; Jeong Won Jahng; Jong-Ho Lee
Journal:  Neural Regen Res       Date:  2012-09-15       Impact factor: 5.135

10.  Comparison of articular cartilage repair with different hydrogel-human umbilical cord blood-derived mesenchymal stem cell composites in a rat model.

Authors:  Jun Young Chung; Minjung Song; Chul-Won Ha; Jin-A Kim; Choong-Hee Lee; Yong-Beom Park
Journal:  Stem Cell Res Ther       Date:  2014-03-19       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.